Kairos Pharma Provides Business Update and Outlook into 2025

KAPA 01.21.2025

Full Press ReleaseSEC FilingsOur KAPA Tweets

About Gravity Analytica

Recent News

  • 01.21.2025 - Kairos Pharma Provides Business Update and Outlook into 2025
  • 01.07.2025 - Kairos Pharma to Present at the Lytham Partners Investor Healthcare Summit
  • 12.03.2024 - Kairos Pharma Adds City of Hope Cancer Center for Phase 2 ENV105 Clinical Trial

Recent Filings

  • 01.17.2025 - 8-K Current report
  • 11.25.2024 - 4 Statement of changes in beneficial ownership of securities
  • 11.19.2024 - EX-99.1 EX-99.1
Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com